Don’t miss out on our new brand and our new home! Precision NanoSystems has completed our integration with Cytiva and can now offer so much more!
Our end-to-end workflow solutions are your helping hand to advance your therapeutics from concept to commercial delivery.
We are closing this YouTube account on 31 May 2024 - follow @Cytiva and find out what’s new!

#lipidnanoparticles
#nanomedicine
#NanoAssemblr
#Ignite
#lipidformulation

Turning Industry Challenges into Innovation: NanoAssemblr™ Commercial Formulation System
6:02
Turning Industry Challenges into Innovation: NanoAssemblr™ Commercial Formulation System
Scaled Up Production of mRNA-LNPs: Strategies & Parameters
28:05
Scaled Up Production of mRNA-LNPs: Strategies & Parameters
Optimized and Scalable LNP Composition for RNA Vaccine Delivery
43:40
Optimized and Scalable LNP Composition for RNA Vaccine Delivery
Maximizing Yield and Purity in RNA-LNP Downstream Processing
1:01:44
Maximizing Yield and Purity in RNA-LNP Downstream Processing
Standardizing Scale-up: Insights into Producing Clinical and Commercial RNA-LNP Drug Products
38:42
Standardizing Scale-up: Insights into Producing Clinical and Commercial RNA-LNP Drug Products
Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and Challenges
58:58
Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and Challenges
RNA-LNP Therapeutics Panel Discussion
1:30:45
RNA-LNP Therapeutics Panel Discussion
Ionizable Lipids to Optimize RNA-LNP Delivery
2:54
Ionizable Lipids to Optimize RNA-LNP Delivery
NanoAssemblr Commercial Formulation System Overview
2:25
NanoAssemblr Commercial Formulation System Overview
Enabling and advancing mRNA-LNP medicines from concept to clinic
51:54
Enabling and advancing mRNA-LNP medicines from concept to clinic
Accelerate development by outsourcing MRNA–LNP formulations to a CDMO
45:00
Accelerate development by outsourcing MRNA–LNP formulations to a CDMO
Novel Ionizable Lipid Portfolio for Enabling Non-Viral Delivery
38:49
Novel Ionizable Lipid Portfolio for Enabling Non-Viral Delivery
Manufacture of LNPs for RNA delivery
24:36
Manufacture of LNPs for RNA delivery
LNPs: Therapeutics for Acute Myeloid Leukaemia
26:36
LNPs: Therapeutics for Acute Myeloid Leukaemia
Top 5 Things to know about our Lipid Nanoparticle Portfolio
2:27
Top 5 Things to know about our Lipid Nanoparticle Portfolio
New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy
45:23
New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy
RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.
9:39
RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.
Lipid Nanoparticle Portfolio for Enabling Non-Viral Delivery - Dr. Anitha Thomas
1:03:31
Lipid Nanoparticle Portfolio for Enabling Non-Viral Delivery - Dr. Anitha Thomas
Biomimetic LNPs for Enhanced Targeting of Inflamed Tissue: What Are the Challenges?
29:24
Biomimetic LNPs for Enhanced Targeting of Inflamed Tissue: What Are the Challenges?
CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform
23:48
CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform
Robust low-volume production of lipid nanoparticles for nucleic acid drug discovery & screening
14:26
Robust low-volume production of lipid nanoparticles for nucleic acid drug discovery & screening
Proteolipid vesicles: A novel delivery system for safe and effective delivery of nucleic acids
25:00
Proteolipid vesicles: A novel delivery system for safe and effective delivery of nucleic acids
Building an LNP process for the Omega platform: a case study
22:41
Building an LNP process for the Omega platform: a case study
CMC Considerations for Developing an Effective mRNA/LNP Therapeutic
26:29
CMC Considerations for Developing an Effective mRNA/LNP Therapeutic
Developing a platform process for LNP manufacture
20:40
Developing a platform process for LNP manufacture
Transient Expression of mRNA Lipid Nanoparticle-based Chimeric Antigen Receptors for Immunotherapy
28:48
Transient Expression of mRNA Lipid Nanoparticle-based Chimeric Antigen Receptors for Immunotherapy
Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid Nanoparticles
1:00:07
Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid Nanoparticles
Endosomal Escape of Lipid Nanoparticles: Novel Insights Using Reflectivity Techniques
18:58
Endosomal Escape of Lipid Nanoparticles: Novel Insights Using Reflectivity Techniques
Manufacturing RNA lipid nanoparticles to deliver high quality transformative medicines
2:36
Manufacturing RNA lipid nanoparticles to deliver high quality transformative medicines
Transient Expression of mRNA-LNP-based Chimeric Antigen Receptors for Safe Immunotherapy
23:24
Transient Expression of mRNA-LNP-based Chimeric Antigen Receptors for Safe Immunotherapy